Abstract
Chronic kidney disease-associated pruritus (CKD-associated pruritus, formerly named “uraemic pruritus”) remains a frequent and sometimes tormenting problem in patients with advanced or end-stage renal disease.1 Many attempts have been made to relieve this bothersome symptom in affected patients, but with limited success in general. After a new treatment option is reported to be effective, only a little time elapses before conflicting results concerning CKD-associated pruritus are published. In the meantime patients’ and physicians’ mood changes from euphoria to disillusionment. This happened with erythropoetin2, 3 and naltrexone4, 5 as the last propagated treatment modalities in this respect.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
